Clinical analysis and management of gestational trophoblastic diseases: a 90 cases study
- PMID: 23675154
- PMCID: PMC3614797
Clinical analysis and management of gestational trophoblastic diseases: a 90 cases study
Abstract
Objective: The aim of the study was to identify the incidence, diagnosis, therapeutic and histological particularities of molar pregnancies and to evaluate our management of gestational trophoblastic tumors (GTT) according to the recommendations of FIGO.
Methods: This was a retrospective study of 90 patients who were diagnosed with molar pregnancy from January 1991 to December 2007. After remission, post molar pregnancy surveillance was continued for one year. Patients whose condition required chemotherapy for GTT were attributed a FIGO/WHO score.
Results: Molar pregnancy occurred in 90 women. The frequency of molar pregnancy was 1 per 1124 pregnancies. The mean age was 32.21 years. Molar pregnancies were more frequent in pauciparous patients (52.24%). At diagnosis, the median gestational age was 13 weeks. The main presenting symptom was metrorrhagia (90%). Treatment consisted in uterine evacuation by suction curettage. Histological findings were complete mole in 66.66% of the cases and partial mole in 33.33% of the cases. 81 patients (90%) achieved remission without chemotherapy and 9 patients (10%) had FIGO stage I GTT. They achieved remission with a monochemotherapy.
Conclusion: The practice of ultrasonography in the first trimester of pregnancy allows an early diagnosis of molar pregnancy and an adequate treatment and follow-up.
Keywords: chemotherapy; gestational trophoblastic tumors; human chorionic gonadotropin; hydatiform mole; ultrasonography.
Similar articles
-
Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.Am J Obstet Gynecol. 2021 Oct;225(4):401.e1-401.e9. doi: 10.1016/j.ajog.2021.05.006. Epub 2021 May 18. Am J Obstet Gynecol. 2021. PMID: 34019886
-
Surveillance for gestational trophoblastic neoplasia following molar pregnancy: a cost-effectiveness analysis.Am J Obstet Gynecol. 2021 Nov;225(5):513.e1-513.e19. doi: 10.1016/j.ajog.2021.05.031. Epub 2021 May 29. Am J Obstet Gynecol. 2021. PMID: 34058170 Free PMC article.
-
Is chemotherapy necessary for patients with molar pregnancy and human chorionic gonadotropin serum levels raised but falling at 6months after uterine evacuation?Gynecol Oncol. 2016 Dec;143(3):558-564. doi: 10.1016/j.ygyno.2016.09.012. Gynecol Oncol. 2016. PMID: 27640962
-
Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?Eur J Obstet Gynecol Reprod Biol. 2018 Apr;223:50-55. doi: 10.1016/j.ejogrb.2018.02.001. Epub 2018 Feb 15. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29477553 Review.
-
State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia.J Natl Compr Canc Netw. 2019 Nov 1;17(11):1396-1401. doi: 10.6004/jnccn.2019.7364. J Natl Compr Canc Netw. 2019. PMID: 31693988 Review.
Cited by
-
Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.Obstet Gynecol. 2020 Jan;135(1):12-23. doi: 10.1097/AOG.0000000000003566. Obstet Gynecol. 2020. PMID: 31809433 Free PMC article.
-
Gestational trophoblastic diseases - literature review and atypical case reports.Rom J Morphol Embryol. 2025 Jan-Mar;66(1):7-30. doi: 10.47162/RJME.66.1.01. Rom J Morphol Embryol. 2025. PMID: 40384188 Free PMC article. Review.
-
Magnitude and its associated factors of gestational trophoblastic disease in East African countries, systematic review and meta-analysis.Front Oncol. 2025 May 29;15:1515246. doi: 10.3389/fonc.2025.1515246. eCollection 2025. Front Oncol. 2025. PMID: 40510147 Free PMC article. Review.
References
-
- Berkowitz RS, Goldstein DP. Diagnosis and management of primary hydatidiform mole. Obstet. Gynecol. Clin. North. Am. 1988;15:491–503. - PubMed
-
- Ngan HY. Gestational trophoblastic disease. Reviews in Gynaecological Practice. 2003;3:142–147.
-
- Soto-Wright V, Bernstein M, Golstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet. Gynecol. 1995;86:775–779. - PubMed
-
- Harriet OS. Gestational trophoblastic disease, epidemiology and tends. Clin. Obstet. Gynecol. 2003;46:541–545. - PubMed
-
- Mangili G, Garavaglia E, Cavoretto P, et al. Clinical presentation of hydatidiform mole in northern Italy: has it changed in the last twenty years? Am. J. Obstet. Gynecol. 2008;198:302.e1–302.e4. - PubMed
LinkOut - more resources
Full Text Sources